TY - JOUR
T1 - An adolescent female having hepatocellular carcinoma associated with hepatitis B virus genotype H with a deletion mutation in the pre-S2 region
AU - Oba, Utako
AU - Koga, Yuhki
AU - Hoshina, Takayuki
AU - Suminoe, Aiko
AU - Abe, Kenji
AU - Hayashida, Makoto
AU - Taguchi, Tomoaki
AU - Hara, Toshiro
N1 - Publisher Copyright:
© 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - The genotypes of hepatitis B virus (HBV) have a distinct geographical distribution, with HBV genotype H being very rare in East Asia, including Japan. We herein report the case of a 12-year-old Japanese female with hepatocellular carcinoma (HCC) who exhibited HBV genotype H. Notably, the HBV isolated from the patient had a deletion mutation in the pre-S2 region. The genome of HBV genotype H in the patient with HCC has not been analyzed in detail. The deletion mutations in the pre-S2 region, which may play an important role in hepatocarcinogenesis in children, can also present in genotype H.
AB - The genotypes of hepatitis B virus (HBV) have a distinct geographical distribution, with HBV genotype H being very rare in East Asia, including Japan. We herein report the case of a 12-year-old Japanese female with hepatocellular carcinoma (HCC) who exhibited HBV genotype H. Notably, the HBV isolated from the patient had a deletion mutation in the pre-S2 region. The genome of HBV genotype H in the patient with HCC has not been analyzed in detail. The deletion mutations in the pre-S2 region, which may play an important role in hepatocarcinogenesis in children, can also present in genotype H.
UR - http://www.scopus.com/inward/record.url?scp=84931266918&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84931266918&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2014.10.015
DO - 10.1016/j.jiac.2014.10.015
M3 - Article
C2 - 25442807
AN - SCOPUS:84931266918
SN - 1341-321X
VL - 21
SP - 302
EP - 304
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 4
ER -